Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015☆

[1]  J. Ateudjieu,et al.  Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone “beep” in a Cameroon health district: a randomized field trial , 2015, The Pan African medical journal.

[2]  Robert T. Chen,et al.  Enhancing vaccine safety capacity globally: A lifecycle perspective. , 2015, Vaccine.

[3]  Hua-Qing Wang,et al.  Surveillance of adverse events following immunization in China: Past, present, and future. , 2015, Vaccine.

[4]  Da-wei Liu,et al.  Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China. , 2014, Vaccine.

[5]  B. Genton,et al.  Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial. , 2014, Vaccine.

[6]  H. Larson,et al.  Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. , 2013, Vaccine.

[7]  Janice E Graham,et al.  Capacity for a global vaccine safety system: the perspective of national regulatory authorities. , 2012, Vaccine.

[8]  Weizhong Yang,et al.  Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. , 2011, The New England journal of medicine.

[9]  Manya Magnus,et al.  Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. , 2008, Vaccine.

[10]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.